In the 12 months to Nov 8, 2026, on the open market: sold $9.9M of IMNM. Filed a median of 1 business day after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
Insider purchases above the line: $0Insider sales below: $9.9M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
IMNMSold: Immunome Inc. Aug 12, 202611,048 sharesfiled Aug 12, 202692,211 shares held directly after, as filed10b5-1 planfiling$301K
IMNMSold: Immunome Inc. Aug 11, 202662,291 sharesfiled Aug 12, 20260 shares held indirectly after, as filed10b5-1 planfiling$1.6M
IMNMSold: Immunome Inc. Aug 10, 202610,125 sharesfiled Aug 12, 202662,291 shares held indirectly after, as filed10b5-1 planfiling$264K
IMNMSold: Immunome Inc. Aug 7, 202615,248 sharesfiled Aug 10, 202672,416 shares held indirectly after, as filed10b5-1 planfiling$397K
IMNMSold: Immunome Inc. Aug 6, 202620,840 sharesfiled Aug 10, 202687,664 shares held indirectly after, as filed10b5-1 planfiling$543K
IMNMSold: Immunome Inc. Jul 7, 202616,906 sharesfiled Jul 7, 2026108,504 shares held indirectly after, as filed10b5-1 planfiling$409K
IMNMSold: Immunome Inc. Jul 6, 202683,094 sharesfiled Jul 7, 2026125,410 shares held indirectly after, as filed10b5-1 planfiling$2.0M
IMNMSold: Immunome Inc. Jun 30, 2026101,050 sharesfiled Jul 2, 2026308,504 shares held indirectly after, as filed10b5-1 planfiling$2.1M
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
